DBXZ 📈 Xtrackers - Xtrackers MSCI - Overview
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU0292097747 • UK Large-Cap Equity
DBXZ: UK Stocks, Equities, ESG, ETF
‣ Company URL: http://www.dws.lu ‣ Domicile: Luxembourg ‣ Index Name: Morningstar UK All Cap TME NR GBP
Additional Sources for DBXZ ETF
DBXZ ETF Overview
| Market Cap in USD | 355m |
| Category | UK Large-Cap Equity |
| TER | 0.18% |
| IPO / Inception | 2007-06-15 |
DBXZ ETF Ratings
| Growth 5y | 29.6% |
| Fundamental | - |
| Dividend | 35.3% |
| Rel. Strength Industry | -27.1 |
| Analysts | - |
| Fair Price Momentum | 4.75 EUR |
| Fair Price DCF | - |
DBXZ Dividends
| Dividend Yield 12m | 4.08% |
| Yield on Cost 5y | 4.11% |
| Annual Growth 5y | -3.96% |
| Payout Consistency | 81.4% |
DBXZ Growth Ratios
| Growth Correlation 3m | 6.1% |
| Growth Correlation 12m | 91.3% |
| Growth Correlation 5y | 52% |
| CAGR 5y | 0.12% |
| CAGR/Mean DD 5y | 0.01 |
| Sharpe Ratio 12m | 0.73 |
| Alpha | -6.37 |
| Beta | 0.67 |
| Volatility | 14.06% |
| Current Volume | 0.8k |
| Average Volume 20d | 225.2k |
What is the price of DBXZ stocks?
As of January 03, 2025, the stock is trading at EUR 4.91 with a total of 789 shares traded.
Over the past week, the price has changed by -0.49%, over one month by -2.50%, over three months by -1.74% and over the past year by +13.11%.
As of January 03, 2025, the stock is trading at EUR 4.91 with a total of 789 shares traded.
Over the past week, the price has changed by -0.49%, over one month by -2.50%, over three months by -1.74% and over the past year by +13.11%.
Is Xtrackers - Xtrackers MSCI a good stock to buy?
Neither. Based on ValueRay Analyses, Xtrackers - Xtrackers MSCI is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 29.55 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DBXZ as of January 2025 is 4.75. This means that DBXZ is currently overvalued and has a potential downside of -3.26%.
Neither. Based on ValueRay Analyses, Xtrackers - Xtrackers MSCI is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 29.55 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DBXZ as of January 2025 is 4.75. This means that DBXZ is currently overvalued and has a potential downside of -3.26%.
Is DBXZ a buy, sell or hold?
Xtrackers - Xtrackers MSCI has no consensus analysts rating.
Xtrackers - Xtrackers MSCI has no consensus analysts rating.
What are the forecast for DBXZ stock price target?
According to ValueRays Forecast Model, DBXZ Xtrackers - Xtrackers MSCI will be worth about 5.2 in January 2026. The stock is currently trading at 4.91. This means that the stock has a potential upside of +6.52%.
According to ValueRays Forecast Model, DBXZ Xtrackers - Xtrackers MSCI will be worth about 5.2 in January 2026. The stock is currently trading at 4.91. This means that the stock has a potential upside of +6.52%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 5.2 | 6.5% |